Patrick J Klein Selected Research

Patrick J Klein Research Topics

Disease

15	Neoplasms (Cancer) 01/2019 - 01/2006
4	Hepatocellular Carcinoma (Hepatoma) 06/2009 - 01/2006
3	Inflammation (Inflammations) 10/2021 - 04/2011
2	Neutropenia 12/2018 - 01/2013
2	Carcinoma (Carcinomatosis) 12/2018 - 01/2013
2	Experimental Arthritis 07/2015 - 04/2011
2	Rheumatoid Arthritis 07/2015 - 04/2011
2	Constipation 02/2011 - 12/2009
2	Neuroblastoma 07/2006 - 01/2006
1	Cytokine Release Syndrome 10/2021
1	Osteosarcoma (Osteogenic Sarcoma) 01/2019
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019
1	Carcinogenesis 01/2015
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2013
1	Neoplasm Metastasis (Metastasis) 01/2013
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2012
1	Ovarian Epithelial Carcinoma 11/2012
1	Ovarian Neoplasms (Ovarian Cancer) 11/2012
1	Arthritis (Polyarthritis) 04/2011
1	Anaphylaxis (Anaphylactic Shock) 09/2009
1	Hypersensitivity (Allergy) 09/2009
1	Hepatitis 06/2009
1	Liver Neoplasms (Liver Cancer) 01/2006
1	Hyperplasia 07/2002
1	Aflatoxin Poisoning 07/2002
1	Weight Gain 07/2002
1	Long Term Adverse Effects 07/2002

Drug/Important Bio-Agent (IBA)

12	Folic Acid (Vitamin M)FDA LinkGeneric 01/2019 - 09/2009
4	EC145IBA 11/2012 - 09/2009
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 06/2009 - 01/2006
3	tubulysin BIBA 06/2017 - 09/2009
3	HydrazinesIBA 04/2016 - 12/2009
3	AlkaloidsIBA 11/2012 - 12/2009
2	Chimeric Antigen ReceptorsIBA 10/2021 - 01/2019
2	Fluorescein (Funduscein)FDA LinkGeneric 01/2019 - 09/2009
2	Fluorescein-5-isothiocyanate (FITC)IBA 01/2019 - 09/2009
2	LigandsIBA 01/2019 - 11/2012
2	EC0531IBA 12/2018 - 06/2017
2	EC0305IBA 06/2017 - 09/2009
2	U 0126 (UO 126)IBA 06/2009 - 01/2006
2	Mitogen-Activated Protein KinasesIBA 06/2009 - 07/2006
2	2- (2- chloro- 4- iodophenylamino)- N- cyclopropylmethoxy- 3,4- difluoro- 5- bromobenzamideIBA 06/2009 - 01/2006
1	Interleukin-6 (Interleukin 6)IBA 10/2021
1	InterleukinsIBA 10/2021
1	Folate Receptor 2IBA 10/2021
1	isothiocyanic acidIBA 01/2019
1	HydrazonesIBA 04/2016
1	AcetoneIBA 04/2016
1	Antineoplastic Agents (Antineoplastics)IBA 04/2016
1	Acetic Acid (Vinegar)FDA LinkGeneric 04/2016
1	BuffersIBA 04/2016
1	Mannitol (Osmitrol)FDA LinkGeneric 04/2016
1	Alanine (L-Alanine)FDA Link 04/2016
1	EC0565IBA 07/2015
1	CarcinogensIBA 01/2015
1	EC0905IBA 01/2013
1	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 12/2011
1	Etanercept (Enbrel)FDA Link 04/2011
1	EC 0746IBA 04/2011
1	Methotrexate (Mexate)FDA LinkGeneric 04/2011
1	AminopterinIBA 04/2011
1	EC 0489IBA 02/2011
1	HaptensIBA 09/2009
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 06/2009
1	Proteins (Proteins, Gene)FDA Link 06/2009
1	Mitogen-Activated Protein Kinase 3IBA 06/2009
1	1,3-butadiene (divinyl)IBA 06/2009
1	mirdametinibIBA 01/2008
1	Transforming Growth Factor alpha (TGF-alpha)IBA 01/2008
1	Phosphotransferases (Kinase)IBA 07/2006
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 06/2006
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 06/2006
1	parthenolideIBA 06/2006
1	N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA 06/2006
1	NF-kappa B (NF-kB)IBA 06/2006
1	Butylated Hydroxytoluene (BHT)IBA 07/2002
1	AntioxidantsIBA 07/2002

Therapy/Procedure

6	Therapeutics 10/2021 - 07/2006
2	Drug Therapy (Chemotherapy) 01/2019 - 06/2006
1	Intravenous Injections 11/2012
1	Immunotherapy 09/2009
1	Chemoprevention 01/2008